J.-M. Vannetzel

Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients.

S. Culine, J. Droz, J. Misset, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.

Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer.

P. Fumoleau, V. Diéras, T. Bachelot, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.